Skip to main content
SpringerLink
Log in

Trial inclusion criteria affect rate of psychiatric AEs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Willemen MJC, Mantel-Teeuwisse AK, Straus SMJM, Egberts ACG, Leufkens HGM.Reporting of Psychiatric Adverse Events in Randomised Clinical Trials. 10th Annual Meeting of the International Society of Pharmacovigilance: abstr. 100, 3 Nov 2010. Available from: URL: http://adisonline.com/drugsafety/citation/2010/33100/abstracts%5f%5f10th%5fisop%5fannual%5fmeeting.9.aspx

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trial inclusion criteria affect rate of psychiatric AEs. React. Wkly. 1327, 3 (2010). https://doi.org/10.2165/00128415-201013270-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013270-00007

Keywords

Search

Navigation